The ABCB1/ABCG2 inhibitor elacridar is a more potent pharmaco-enhancer compared to tariquidar for treatment of intracranial tumors with small molecule drugs
European Journal of Cancer（2022）
关键词
abcb1/abcg2 inhibitor elacridar,intracranial tumors,small molecule drugs,potent pharmacoenhancer
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要